CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹380 Cr | ₹21 Cr | ₹-55 Cr | ₹-109 Cr | ₹-146 Cr |
What is the latest Net Cash Inflow / Outflow ratio of CIPLA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹380 Cr |
| Mar2025 | ₹21 Cr |
| Mar2024 | ₹-55 Cr |
| Mar2023 | ₹-109 Cr |
| Mar2022 | ₹-146 Cr |
How is Net Cash Inflow / Outflow of CIPLA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹380 Cr | 1,706.37 | |
| Mar2025 | ₹21 Cr | Positive | |
| Mar2024 | ₹-55 Cr | Negative | |
| Mar2023 | ₹-109 Cr | Negative | |
| Mar2022 | ₹-146 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹112,540.5 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| MANKIND PHARMA | ₹109,622.0 Cr | 3% | 13.9% | 17.8% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -1.3% |
6.1% |
-6.9% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses